Resveratrol: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 38: | Line 38: | ||
[[Category:BME and | [[Category:BME and mitObesity]] |
Revision as of 22:35, 19 January 2020
Description
Resveratrol is a natural bioactive phenol prouced by several plants with antioxidant and anti-inflammatory effects. Dietary intake as nutraceutical is discussed for targeting mitochondria with a wide spectrum of action in degenerative diseases.
Communicated by Gnaiger E (2020-01-14).
Resveratrol and mitObesity
- Banday 2020 J Am Heart Assoc
- Beaudoin 2013 Am J Physiol Regul Integr Comp Physiol
- Beaudoin 2014 J Physiol
- Bellance 2009 Int J Biochem Cell Biol
- Cardoso 2017 Biochim Biophys Acta
- Cassereau 2019 Exp Neurol
- Chowdhury 2012 Brain
- Cumero 2012 Br J Pharmacol
- Da Silva 2017 Neurotox Res
- De Moura 2017 Neurotox Res
- Fisar 2016b Folia Biol (Praha)
- Hirzel 2013 J Recept Signal Transduct Res
- Jarolim 2004 FEMS Yeast Res
- Jung 2012 J Med Food
- Layne 2017 Contemp Clin Trials
- Morato 2015 Cell Death Differ
- Most 2017 Eur J Clin Nutr
- Most 2016 Am J Clin Nutr
- Rodriguez-Enriquez 2019 Toxicol Appl Pharmacol
- Smith 2013 J Physiol
- Timmers 2011 Cell Metab
- Timmers 2016 Diabetes Care
- Williams 2014 PLoS One
- Zhou 2018 Toxicology
- Zhao Y, Chen B, Shen J, Wan L, Zhu Y, Yi T, Xiao Z (2017) The beneficial effects of Quercetin, Curcumin, and Resveratrol in obesity. Oxid Med Cell Longev 2017:1459497. - https://www.ncbi.nlm.nih.gov/pubmed/29138673
- Li B, Xiao X, Miao Y, Guo L, Zhen J, Li X, Jiang B, Hu Z (2020) Resveratrol alleviates obesity-associated podocyte injury in ovariectomized obese rats. Exp Ther Med 19:123-30. - https://www.ncbi.nlm.nih.gov/pubmed/31853281
- Yang YSH, Li ZL, Shih YJ, Bennett JA, Whang-Peng J, Lin HY, Davis PJ, Wang K (2019) Herbal medicines attenuate PD-L1 expression to induce anti-proliferation in obesity-related cancers. Nutrients 11 pii: E2979. - https://www.ncbi.nlm.nih.gov/pubmed/31817534
- Yang AJT, Frendo-Cumbo S, MacPherson REK (2019) Resveratrol and metformin recover prefrontal cortex AMPK activation in diet-induced obese mice but reduce BDNF and synaptophysin protein content. J Alzheimers Dis 71:945-56. - https://www.ncbi.nlm.nih.gov/pubmed/31450493